Short Interest in Genscript Biotech Co. (OTCMKTS:GNNSF) Drops By 5.7%

Genscript Biotech Co. (OTCMKTS:GNNSF) was the recipient of a large drop in short interest in May. As of May 31st, there was short interest totalling 6,557,600 shares, a drop of 5.7% from the May 15th total of 6,955,800 shares. Based on an average daily volume of 154,500 shares, the days-to-cover ratio is currently 42.4 days.

Genscript Biotech Stock Performance

Shares of Genscript Biotech stock opened at C$1.05 on Tuesday. The business has a fifty day simple moving average of C$1.43 and a 200-day simple moving average of C$1.97. Genscript Biotech has a fifty-two week low of C$1.05 and a fifty-two week high of C$3.20.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.